Breaking News Instant updates and real-time market news.

ZG

Zillow

$33.18

-0.93 (-2.73%)

, Z

Zillow

$33.31

-1.06 (-3.08%)

10:25
10/07/16
10/07
10:25
10/07/16
10:25

On The Fly: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Zillow (ZG, Z) initiated with a Buy at Needham. 2. AMD (AMD) initiated with an Equal Weight at Barclays. 3. Aflac (AFL) was initiated with an Underperform at Credit Suisse while the firm also initiated Prudential (PRU) and Assurant (AIZ) with a Neutral. 4. Fifth Third (FITB) initiated with a Neutral at Wedbush. 5. GW Pharmaceuticals (GWPH) initiated with a Buy at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

ZG

Zillow

$33.18

-0.93 (-2.73%)

Z

Zillow

$33.31

-1.06 (-3.08%)

AMD

AMD

$6.96

0.18 (2.65%)

AFL

Aflac

$71.79

-0.28 (-0.39%)

PRU

Prudential

$84.39

-0.617 (-0.73%)

AIZ

Assurant

$90.10

0.16 (0.18%)

FITB

Fifth Third

GWPH

GW Pharmaceuticals

$133.10

-0.35 (-0.26%)

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 26

    Oct

  • 03

    Nov

  • 08

    Nov

  • 09

    Nov

  • 14

    Nov

  • 15

    Dec

  • 06

    Jun

ZG Zillow
$33.18

-0.93 (-2.73%)

10/07/16
NEED
10/07/16
INITIATION
NEED
Buy
Zillow initiated at Needham
As noted earlier, Needham initiated coverage of Zillow with a $40 price target and a Buy rating. Analyst Kerry Rice expects real estate agents to spend more on Zillow in coming years due to the website's high popularity with consumers. Rice thinks that Zillow will also benefit by expanding into "adjacent markets such as mortgages and rentals," and Rice predicts that the company's margins will expand.
10/07/16
NEED
10/07/16
INITIATION
Target $40
NEED
Buy
Zillow initiated with a Buy at Needham
Needham analyst Kerry Rice initiated Zillow with a Buy and a $40 price target.
08/04/16
08/04/16
NO CHANGE

On The Fly: After Hours Movers
UP AFTER EARNINGS: Pacific Biosciences (PACB), up 17%... MasTec (MTZ), up 9.6%... Aratana Therapeutics (PETX), up 9.2%... Lion's Gate (LGF), up 6.4%... Priceline (PCLN), up 5.7%... Ubiquiti (UBNT), up 5.5%... MercadoLibre (MELI), up 4.1%... Organovo (ONVO), up 3.9%... Kraft Heinz (KHC), up 3.3%... EOG Resources (EOG), up 2.8%... Monster Beverage (MNST), up 1.2%... TASER (TASR), up 1.2%... Take-Two (TTWO), up 0.9%... Activision Blizzard (ATVI), up 1%... BioMarin (BMRN), up 0.4%. ALSO HIGHER: Egalet (EGLT), up 31.2% after the company announced that an FDA advisory committee recommended approval of its ARYMO ER drug... Rackspace (RAX), up 17.6% after the Wall Street Journal reported that the company was near a takeover deal with a private equity buyer... Osiris (OSIR), up 8.5% after it said that the manuscript from its prospective trial using Grafix was published. DOWN AFTER EARNINGS: Hortonworks (HDP), down 26.2%... PDL BioPharma (PDLI), down 17.5%... FireEye (FEYE), down 15.8%... Sierra Wireless (SWIR), down 15.6%... Aquinox (AQXP), down 14.7%... Zynga (ZNGA), down 9.4%... Universal Display (OLED), down 8.2%... Weight Watchers (WTW), down 7.6%... Zillow Group (Z, ZG), down 5.5%... Arista Networks (ANET), down 4.5%... Noodles & Company (NDLS), down 4.3%... Merrimack (MACK), down 1.7%... Bankrate (RATE), down 1.7%.
07/14/16
ADAM
07/14/16
NO CHANGE
Target $40
ADAM
Buy
Zillow price target raised to $40 from $34 at Canaccord
Canaccord raised its price target on Zillow (ZG) to $40 from $34 as the company continues to execute well with its integration of its Trulia acquisition and creating value for its customers. The firm also noted the settlement of its News Corp. (NWSA) litigation and expects future margin expansion. Canaccord reiterated its Buy rating on Zillow shares.
Z Zillow
$33.31

-1.06 (-3.08%)

06/07/16
ADAM
06/07/16
NO CHANGE
Target $34
ADAM
Buy
Zillow settlement with News Corp. better than feared, says Canaccord
Canaccord said Zillow's (Z) settlement with News Corp. (NWSA) was better than their worst fears. The firm said the settlement amount was well below what News Corp. was seeking, but nearly 2.5 times what management had expensed. The firm, which believes the settlement points to a more rational competitive environment, reiterated its Buy rating and $34 price target on Zillow shares.
06/07/16
06/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sarepta (SRPT) upgraded to Outperform from Neutral at Wedbush with analyst Heather Behanna saying she believes a statistically significant increase of dystrophin over baseline should be enough to secure an accelerated approval for the company's Duchenne muscular dystrophy treatment eteplirsen. Behanna raised her price target for the shares to $36 from $14. 2. Zillow (Z, ZG) upgraded to Equal Weight from Underweight at Barclays with analyst Christopher Merwin arguing that the lawsuit settlement sum is "surprisingly small" since News Corp.'s (NWSA) Move was originally seeking $2B in damages. 3. Synergy Resources (SYRG) upgraded to Overweight from Equal Weight at Stephens with analysts led by Mike Kelly saying Synergy offers top-tier growth potential, has an immaculate balance sheet and improved inventory, and recent weakness provides a compelling entry point. 4. Concho Resources (CXO) upgraded to Accumulate from Neutral at Seaport Global with analysts led by Mike Kelly saying Concho has high-quality exposure to the Delaware Basin and is poised for further credit and growth potential. 5. Noble Energy (NBL) upgraded to Buy from Neutral at Seaport Global with analysts led by Mike Kelly saying shares offer strong growth and cheap valuation versus peers with meaningful capital efficiency improvements in the DJ Basin that will improve IRRs to over 80%. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage,
09/12/16
MSCO
09/12/16
NO CHANGE
MSCO
Internet sector downgraded to In-Line from Attractive at Morgan Stanley
Morgan Stanley analysts led by Brian Nowak lowered the Internet sector view to In-Line from Attractive due to more balanced risk/reward. The analyst favors large caps and remains bullish on Facebook (FB), Priceline (PCLN), Alphabet Class A (GOOGL), and Amazon.com (AMZN), and Zillow (Z). The firm downgraded TrueCar (TURE), Rubicon Project (RUBI), and RetailMeNot (SALE) to Underweight from Equal Weight.
AMD AMD
$6.96

0.18 (2.65%)

10/07/16
LEHM
10/07/16
INITIATION
Target $7
LEHM
Equal Weight
AMD initiated with an Equal Weight at Barclays
Barclays analyst Blayne Curtis started AMD with an Equal Weight rating and $7 price target. The company's transformation remains in the early stages and "still faces an uphill battle to recapture meaningful share and achieve sustained profitability," Curtis tells investors in a research note.
09/20/16
09/20/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Betsy Graseck saying shares are trading at a 11 times Price/Earnings for a 3.5% yield, and is one of the "best values" in the S&P 1500 and the sector. 2. Tech Data (TECD) was upgraded to Buy from Hold at Stifel, to Buy from Underperform at CLSA, and to Buy from Neutral at BofA/Merrill. 3. AMD (AMD) upgraded to Market Perform from Underperform at Bernstein. 4. Diamond Offshore (DO) upgraded to Buy from Hold at Evercore ISI with analyst James West saying he believes the offshore rig market will bottom over the next 6-12 months and notes shares are down approximately 42% from its mid-July peak. 5. BHP Billiton (BHP) upgraded to Outperform from Neutral at Macquarie with analyst Alon Olsha citing an increase in coal/manganese forecasts. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/16
SUSQ
09/20/16
INITIATION
Target $6.5
SUSQ
Neutral
AMD initiated with a Neutral at Susquehanna
Susquehanna analyst Christopher Rolland initiated AMD with a Neutral and a $6.50 price target due to valuation.
09/20/16
09/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with a Buy at Nomura. 2. Intel (INTC) was initiated with a Positive at Susquehanna while the firm initiated AMD (AMD) with a Neutral. 3. HSN, Inc. (HSNI) initiated with an Underperform at BofA/Merrill. 4. Bojangles (BOJA) initiated with a Strong Buy at CL King. 5. D.R. Horton (DHI) initiated with an Outperform at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
AFL Aflac
$71.79

-0.28 (-0.39%)

07/06/16
EVER
07/06/16
INITIATION
Target $63
EVER
Sell
Aflac initiated with a Sell at Evercore ISI
Evercore ISI analyst Thomas Gallagher started Aflac with a Sell rating and $63 price target. The market is overly focused on the benefit of a stronger yen and not enough on the negative impact created by negative government yields in Japan, Gallagher tells investors in a research note.
07/07/16
07/07/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aflac (AFL) initiated with a Sell at Evercore ISI with analyst Thomas Gallagher saying the market is overly focused on the benefit of a stronger yen and not enough on the negative impact created by negative government yields in Japan. 2. Shake Shack (SHAK) initiated with an Underperform at Wedbush with analyst Nick Setyan saying he expects its valuation to continue to contract, given that the stock's current valuation implies a much larger sales opportunity than management's guidance. 3. Invivo Therapeutics (NVIV) initiated with a Strong Buy at Raymond James. 4. CBS (CBS) and Time Warner (TWX) initiated with a Buy at Brean Capital. 5. Disney (DIS), Viacom (VIA), and 21st Century Fox (FOX) initiated with a Hold at Brean Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/22/16
WELS
09/22/16
INITIATION
WELS
Market Perform
Aflac coverage resumed with a Market Perform at Wells Fargo
10/07/16
FBCO
10/07/16
INITIATION
Target $75
FBCO
Underperform
Aflac initiated with an Underperform at Credit Suisse
Credit Suisse analyst John Nadel initiated Aflac with an Underperform due to relative share outperformance and expects that low global rates will pressure investment income while the growing disparity between U.S. and Japanese rates will cause an increase in hedging costs. Nadel established a $75 price target on Aflac shares.
PRU Prudential
$84.39

-0.617 (-0.73%)

09/22/16
WELS
09/22/16
INITIATION
WELS
Market Perform
Prudential coverage resumed with a Market Perform at Wells Fargo
09/23/16
GSCO
09/23/16
UPGRADE
Target $93
GSCO
Conviction Buy
Prudential upgraded to Conviction Buy from Neutral at Goldman
Goldman Sachs analyst Michael Kovac upgraded Prudential Financial to Conviction Buy from Neutral and raised his price target for the shares to $93 from $80. The analyst says his earnings estimates are now above consensus due to favorable equity markets, slowing rate pressure and lower currency headwinds. He expects Prudential's earnings to grow 10% in 2017.
09/23/16
09/23/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) upgraded to Overweight from Equal Weight by Barclays analyst Karen Short, who assumed coverage of Wal-Mart and upped the price target for the shares to $87 from $70. Wal-Mart is Short's top pick in the sector, as she believes the retailing giant's "re-emergence as a disruptor" has the potential to "wreak havoc" on many companies in the space. 2. Cabot Oil & Gas (COG) upgraded two notches to Strong Buy from Market Perform by Raymond James analyst Kevin Smith, who said Cabot has improving fundamentals, a "prolific" growth outlook, and an attractive valuation. 3. BioDelivery Sciences (BDSI) upgraded to Buy from Neutral by Janney Capital analyst Ken Trbovich, who said that Endo International (ENDP), which uses BioDelivery's drug delivery technology, has "not yet announced, but clearly won" preferred status for Belbuca relative to market leader Butrans on United Healthcare's Prescription Drug List. 4. Packaging Corp. (PKG) upgraded to Buy from Hold by Deutsche Bank analyst Debbie Jones, citing an "improved earnings trajectory" following the TimBar acquisition. The analyst raised her price target for the shares to $90 from $77. 5. Prudential Financial (PRU) upgraded to Conviction Buy from Neutral by Goldman Sachs analyst Michael Kovac, who says his earnings estimates are now above consensus due to favorable equity markets, slowing rate pressure and lower currency headwinds. He expects Prudential's earnings to grow 10% in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/07/16
FBCO
10/07/16
INITIATION
Target $89
FBCO
Neutral
Prudential initiated with a Neutral at Credit Suisse
Credit Suisse analyst John Nadel initiated Prudential with a Neutral and a $89 price target.
AIZ Assurant
$90.10

0.16 (0.18%)

12/04/15
RHCO
12/04/15
NO CHANGE
RHCO
Assurant price target raised to $105 from $95 at SunTrust
After meeting with Assurant's management, SunTrust thinks the stock has several positive catalysts, including a major cost-saving initiative and faster growth in fees and capital-light premiums. The firm keeps a Buy rating on the shares.
01/07/16
RHCO
01/07/16
NO CHANGE
Target $105
RHCO
Buy
Assurant called a Top Pick at SunTrust
SunTrust analyst Mark Hughes established Assurant as a Top Pick saying the multiple should expand as the company transitions from a value stock into the growth category. He has a Buy rating on the name with a $105 price target.
06/01/16
BOFA
06/01/16
NO CHANGE
BOFA
21st Century, Fox MetLife added to US 1 List, Assurant removed at BofA/Merril
10/07/16
FBCO
10/07/16
INITIATION
Target $93
FBCO
Neutral
Assurant initiated with a Neutral at Credit Suisse
Credit Suisse analyst John Nadel initiated Assurant with a Neutral and a $93 price target.
FITB Fifth Third

10/07/16
JEFF
10/07/16
DOWNGRADE
Target $22
JEFF
Hold
Fifth Third downgraded to Hold from Buy at Jefferies
Jefferies analyst Ken Usdin downgraded Fifth Third Bancorp to Hold saying the shares are reasonably valued following the recent rally. The analyst raised his price target for the stock to $22 from $19.50.
10/06/16
WEDB
10/06/16
INITIATION
Target $22
WEDB
Neutral
Fifth Third initiated with a Neutral at Wedbush
Wedbush analyst Peter Winter initiated Fifth Third with a Neutral and a $22 price target.
10/06/16
WEDB
10/06/16
INITIATION
WEDB
Neutral
Fifth Third initiated with a Neutral at Wedbush
Wedbush analyst Peter Winter initiated Fifth Third with a Neutral rating.
10/07/16
10/07/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tyson Foods (TSN) downgraded to Sell from Hold at Pivotal Research with analyst Timothy Ramey citing the broiler price-fixing alleged in the class action complaint filed on September 2. 2. SolarEdge (SEDG) was downgraded to Sell from Neutral at Goldman while the firm also downgraded First Solar (FSLR) to Neutral from Buy. 3. CIT Group (CIT) downgraded to Hold from Buy at Stifel with analyst Christopher Brendler saying investors should sell into the rally that will result from the "impressive" price that the company received for its aircraft business and the approval of its capital plan by the Fed. 4. Fifth Third (FITB) downgraded to Hold from Buy at Jefferies with analyst Ken Usdin saying the shares are reasonably valued following the recent rally. 5. Blackhawk (HAWK) downgraded to Neutral from Buy at BofA/Merrill with analyst David Chu saying the firm's channel checks indicate that conversions to EMV, the new standard for chip-based debit/credit card transactions, are taking longer than expected, which he believes could impact Blackhawk's 2016 guidance and expectations for 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
GWPH GW Pharmaceuticals
$133.10

-0.35 (-0.26%)

09/26/16
CANT
09/26/16
NO CHANGE
Target $182
CANT
Buy
GW Pharmaceuticals price target raised to $182 from $165 at Cantor
10/04/16
LEER
10/04/16
INITIATION
Target $162
LEER
Outperform
GW Pharmaceuticals reinstated with an Outperform at Leerink
Leerink analyst Paul Matteis resumed coverage of GW Pharmaceuticals with an Outperform rating and $162 price target.
10/07/16
GSCO
10/07/16
INITIATION
Target $189
GSCO
Buy
GW Pharmaceuticals initiated with a Buy at Goldman
Goldman analyst Salveen Richter initiated GW Pharmaceuticals with a Buy saying he expects a solid launch trajectory for lead assets Epidiolex for Dravet Syndrome and Lennox-Gastaut Syndrome, two severe orphan epilepsies, and is modeling $1.6B in world-wide sales. Richter has a $189 price target on shares based on a blend of discounted cash flow for $161 per shares and M&A value of $349 per share.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).

TODAY'S FREE FLY STORIES

SLV

iShares Silver Trust

$17.41

0.17 (0.99%)

12:11
02/24/17
02/24
12:11
02/24/17
12:11
Options
Sizable four-way spread in the Silver Fund as a bullish option play is adjusted »

Sizable four-way spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNB

F.N.B.

$15.52

-0.15 (-0.96%)

, YDKN

Yadkin Financial

$33.15

-0.415 (-1.24%)

12:03
02/24/17
02/24
12:03
02/24/17
12:03
Periodicals
Federal Reserve clears F.N.B.'s takeover of Yadkin, Reuters reports »

The Federal Reserve has…

FNB

F.N.B.

$15.52

-0.15 (-0.96%)

YDKN

Yadkin Financial

$33.15

-0.415 (-1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

NVIDIA

$100.49

-10.27 (-9.27%)

12:01
02/24/17
02/24
12:01
02/24/17
12:01
Options
Heavy trading in Nvidia short-term options as shares stage an aggressive rebound »

Heavy trading in Nvidia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

  • 16

    Mar

  • 20

    Mar

12:00
02/24/17
02/24
12:00
02/24/17
12:00
General news
Treasury Option Action: a round of put activity »

Treasury Option Action: a…

ONCS

OncoSec

$1.42

-0.1 (-6.58%)

11:59
02/24/17
02/24
11:59
02/24/17
11:59
Conference/Events
OncoSec to hold KOL Event Focused on New ASCO-SITC Melanoma Data »

OncoSec's Chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGEN

Miragen Therapeutics

$13.99

-0.06 (-0.43%)

11:55
02/24/17
02/24
11:55
02/24/17
11:55
Hot Stocks
Boulder Ventures V reports 9.9% stake in Miragen Therapeutics »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTG

MGIC Investment

$10.55

-0.055 (-0.52%)

11:51
02/24/17
02/24
11:51
02/24/17
11:51
Options
MGIC Investment with 11.5X average daily optoin volume driven by a bullish play »

MGIC Investment with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$11.06

-0.09 (-0.81%)

11:46
02/24/17
02/24
11:46
02/24/17
11:46
Options
Whiting Petroleum call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

11:45
02/24/17
02/24
11:45
02/24/17
11:45
Conference/Events
Leerink analysts hold an analyst/industry conference call »

In conjunction with the…

11:40
02/24/17
02/24
11:40
02/24/17
11:40
General news
NY Fed Nowcast has Q1 GDP at 3.12% »

NY Fed Nowcast has Q1 GDP…

SPWR

SunPower

$8.99

0.53 (6.26%)

11:36
02/24/17
02/24
11:36
02/24/17
11:36
Options
SunPower put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDRA

Idera Pharmaceuticals

$1.73

0.05 (2.98%)

11:33
02/24/17
02/24
11:33
02/24/17
11:33
Hot Stocks
Idera says achieved 'successful' completion of objectives in Phase 1 trial »

Idera Pharmaceuticals is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRIL

Trillium Therapeutics

$5.90

-0.1 (-1.67%)

11:32
02/24/17
02/24
11:32
02/24/17
11:32
Hot Stocks
Trillium Therapeutics: New TTI-621 data advances understanding of product »

Trillium Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VISI

Volt Information Sciences

$7.35

-0.1 (-1.34%)

, CCRN

Cross Country Healthcare

$15.89

-0.37 (-2.28%)

11:32
02/24/17
02/24
11:32
02/24/17
11:32
Hot Stocks
Volt Information Sciences reports nomination of new independent directors »

Volt Information Sciences…

VISI

Volt Information Sciences

$7.35

-0.1 (-1.34%)

CCRN

Cross Country Healthcare

$15.89

-0.37 (-2.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 08

    Mar

  • 14

    Mar

  • 21

    Mar

MCO

Moody's

$112.59

-0.64 (-0.57%)

11:31
02/24/17
02/24
11:31
02/24/17
11:31
Conference/Events
Leerink analysts hold an analyst/industry conference call »

Analysts provide a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

  • 05

    Mar

VIVHY

Vivendi

$17.95

-0.06 (-0.33%)

, MDIUY

Mediaset

11:28
02/24/17
02/24
11:28
02/24/17
11:28
Periodicals
Milan prosecutors investigating Vivendi over alleged stock manipulation, FT says »

Milan prosecutors are…

VIVHY

Vivendi

$17.95

-0.06 (-0.33%)

MDIUY

Mediaset

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSLR

First Solar

$37.19

3.62 (10.78%)

11:26
02/24/17
02/24
11:26
02/24/17
11:26
Options
First Solar call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

GS

Goldman Sachs

$247.19

-4 (-1.59%)

11:23
02/24/17
02/24
11:23
02/24/17
11:23
Periodicals
Goldman Sachs exec involved in 1MDB dealings leaves bank, WSJ says »

A senior Goldman Sachs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

ALNY

Alnylam

$46.25

0.3 (0.65%)

11:22
02/24/17
02/24
11:22
02/24/17
11:22
Conference/Events
JPMorgan SMid biotech analyst holds an analyst/industry conference call »

SMid Biotech Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

$NSD

NASDAQ Market Internals

11:17
02/24/17
02/24
11:17
02/24/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
02/24/17
02/24
11:16
02/24/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBLY

Mobileye

$46.96

-1.18 (-2.45%)

11:16
02/24/17
02/24
11:16
02/24/17
11:16
Options
Mobileye put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

HBI

Hanesbrands

$20.96

0.04 (0.19%)

11:12
02/24/17
02/24
11:12
02/24/17
11:12
Conference/Events
Hanesbrands management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

WIX

Wix.com

$63.25

-2.3 (-3.51%)

11:10
02/24/17
02/24
11:10
02/24/17
11:10
Conference/Events
Wix.com management to meet with Oppenheimer »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 01

    Mar

  • 02

    Mar

SNCR

Synchronoss

$30.86

-0.03 (-0.10%)

11:09
02/24/17
02/24
11:09
02/24/17
11:09
Periodicals
Synchronoss has withheld 'a great deal' about 'transformation,' SIRF says »

Synchronoss Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.